1 Result(s)

Article

Cost-Effectiveness of Pembrolizumab as an Adjuvant Treatment in Colombia for Melanoma Patients with Lymph Node Involvement After Complete Resection

The KEYNOTE-054 trial found that adjuvant treatment with pembrolizumab improved recurrence-free survival versus placebo in completely resected high-risk stage III melanoma patients. We assessed the cost-effect...

Cesar Lopez-Vinueza, Juan Urrego-Reyes, Fredy R. S. Gutierrez… in Advances in Therapy (2023)